2011 (v1)
Publication
This clinical observation indicates that thyroid function needs to be monitored during therapy with natalizumab, as with other biological medicines, and that thyroid volume and antibody modulation are predictive factors of functional evolution during and after treatment.
Uploaded on: April 14, 2023